| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.054 | 0.4 |